Strategies toward improved control during insulin lispro therapy in IDDM: Importance of basal insulin

Diabetes Care

Volumn 20, Issue 8, 1997, Pages 1287-1289

  Ebeling, Pertti ^a   Jansson, Per Anders ^b   Smith, Ulf ^b   Lalli, Carlo ^c   Bolli, Geremia B ^c   Koivisto, Veikko A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN LISPRO;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE;

EID: 0030746236     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.8.1287     Document Type: Article

References (16)

1. Garg SK, Carmain JA, Braddy KC, Andersen JH, Vignati L, Jennings MK, Chase HP: Pre-meal insulin analogue insulin lispro vs. Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med 13:47-52, 1996
2. Pfützer A, Küstner E, Forst T, Schulze-Schleppinghoff B, Trautmann M, Haslbeck M, Schatz H, Beyer J, the German Insulin Lispro/IDDM Study Group: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol 104:25-30, 1996
3. DiMarchi RD, Chance RE, Long HB, Shields JE, Slieker LJ: Preparation of insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin like growth factor I. Horm Res 41 (Suppl. 2):93-96, 1994
4. Howey DC, Bowsher RR, Brunelle R, Woodworth JR: (Lys (B28), Pro(B29))-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
5. World Health Organization: WHO Expert Committee on Diabetes Mellitus: Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser. no. 646)
6. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
7. 1c by high performance cation exchange chromatography. Clin Chem 26:3-7, 1980
8. Bradley C: Diabetes treatment satisfaction questionnaire (DTSQ). In Handbook of Psychology and Diabetes. Bradley C, Ed. Chur, Switzerland, Harwood Academic, 1994, p. 111-132
9. Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, Appleton D, Binder C, Alberti KGMM: Intensive attention improves glycemic control in insulin dependent diabetes without further advantage from home blood glucose monitoring: results from a controlled trial. Br Med J 285:1233-1240, 1982
10. Torlone E, Modarelli F, Pampanelli S, Epifano L, Lalli C, Kassi G, Del Sindaco P, Perriello G, Di Vincenzo A, Brunetti P, Rambotti AM, Bolli G: Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM. Diabetes Care 19:945-952, 1996
11. Anderson JH, Brunelle RL, DiMarchi R, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, the Multicenter Insulin Lispro Study Group: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 46:265-270, 1997
12. The DCCT Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450-459, 1991
13. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
14. The DCCT Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
15. Carlson MG, Campbell PJ: Intensive insulin therapy and weight gain in IDDM. Diabetes 42:1700-1707, 1993
16. The DCCT Research Group: Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care 11:567-573, 1988